Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GlaxoSmithKline plc
  6. News
  7. Summary
    GSK   GB0009252882

GLAXOSMITHKLINE PLC

(GSK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GlaxoSmithKline : Seeks US Approval for Measles, Mumps, Rubella Vaccine

08/02/2021 | 11:31pm EDT


© MT Newswires 2021
All news about GLAXOSMITHKLINE PLC
10:03aGLAXOSMITHKLINE : Receives Positive Marketing Recommendation From European Medic..
MT
09:34aGLAXOSMITHKLINE : GSK Lands Positive Opinion From European Medicines Agency for ..
MT
08:42aGLAXOSMITHKLINE : GSK receives CHMP positive opinions recommending approval of N..
PU
09/15PharmaSGP Holding SE raises forecast for FY 2021 following completion of acqu..
DJ
09/15CROSSWORD CYBERSECURITY PLC : Appointments URENCO CISO to Advisory Board
AQ
09/15CureVac Cancels mRNA Contracts For COVID-19 Jab
MT
09/14GLAXOSMITHKLINE : Deutsche Bank reiterates its Neutral rating
MD
09/13GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/09GLAXOSMITHKLINE ( '') (FORM 6 K : GlaxoSmithKline plc (the 'Company') (Form 6-K)
PU
09/09FTSE 100 Drops as Pharma, Commodities Fall
DJ
More news
Analyst Recommendations on GLAXOSMITHKLINE PLC
More recommendations
Financials
Sales 2021 33 309 M 45 804 M 45 804 M
Net income 2021 3 875 M 5 328 M 5 328 M
Net Debt 2021 20 960 M 28 823 M 28 823 M
P/E ratio 2021 18,2x
Yield 2021 5,73%
Capitalization 69 819 M 96 028 M 96 011 M
EV / Sales 2021 2,73x
EV / Sales 2022 2,55x
Nbr of Employees 94 066
Free-Float 92,2%
Chart GLAXOSMITHKLINE PLC
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAXOSMITHKLINE PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 1 395,00 GBX
Average target price 1 608,27 GBX
Spread / Average Target 15,3%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Karenann K. Terrell Chief Digital & Technology Officer
Hal V. Barron Executive Director & Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GLAXOSMITHKLINE PLC3.95%96 182
JOHNSON & JOHNSON4.98%434 939
ROCHE HOLDING AG11.70%327 062
PFIZER, INC.21.62%249 329
NOVO NORDISK A/S51.34%233 887
ELI LILLY AND COMPANY36.84%209 456